InvestorsHub Logo
Followers 25
Posts 1198
Boards Moderated 0
Alias Born 04/23/2007

Re: None

Thursday, 06/08/2017 8:05:07 AM

Thursday, June 08, 2017 8:05:07 AM

Post# of 8441
News Alert ! Novavax RSV F Vaccine Phase 2 Clinical Trial Data in Women of Child Bearing Age Published in Vaccine

PR Newswire PR NewswireJune 7, 2017CommentGAITHERSBURG, Md., June 7, 2017 /PRNewswire/ -- Novavax, Inc., (NVAX) today announced that data from the second of two Phase 2 trials of its RSV F protein recombinant nanoparticle vaccine candidate (RSV F Vaccine) in women of child bearing age have been published in the journal Vaccine (the data contained in this publication have been shared in prior scientific conferences). The Company previously announced top line results from this trial in April 2014. Novavax is developing the RSV F Vaccine with the goal of protecting infants from RSV disease.

https://finance.yahoo.com/news/novavax-rsv-f-vaccine-phase-120500126.html

The mind is like a parachute it works best when it is open

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVAX News